the present study may not have been large enough to exclude involvement of a polymorphism with weak effect. Furthermore, in our study sample, to detect the difference between 93/196 and 103/196 with power 0.5, the minimum sample size should be 778. Similarly, to detect the difference between 237/461 and 224/461 in the sample from three Chinese studies with power 0.5, the minimum sample size should be 2487. If a higher power is desired, say, 0.8, then the required minimum sample size would be much greater than those two figures above.
Letters to the Editor novel susceptibility loci for BP, 1 and that BP in the absence of psychosis (nonpsychotic BP) shows evidence of linkage to different loci altogether. 2 This suggests that phenotypic subtypes defined by the presence or absence of psychosis may identify different genetic variants of BP.
In this study, we have taken a more direct approach to the psychosis-related 'spectrum' of BP. Specifically, we have determined if prior evidence of linkage to psychotic BP is sustained or diminished by the inclusion of nonpsychotic BP in the disease phenotype. If the evidence of linkage is sustained or enhanced, it could be argued that the two phenotypic subtypes are genetically related. Conversely, if prior support for linkage is greatly diminished, nonpsychotic BP may differ genetically from psychotic BP.
We have reanalyzed our previous genome-wide scan results for psychotic BP 1 by broadening the affected phenotype to include nonpsychotic BP. (In the previous analysis, 1 nonpsychotic BP was coded as 'unknown'). Our clinical sample, genotyping protocol, and linkage analysis methods have been described. 3 In brief, the total genotyped sample includes 373 individuals in 40 families with high density of BP. 3 A total of 36 of these families are included in the 'psychosis' category, as described.
1 Best-estimate consensus diagnoses are based on the Research Diagnostic Criteria (RDC) 4 using all available sources of information. The models used for the broadened affected phenotype, or 'all BP', are the same as those employed in our initial genome scan 3 : BP1 (manic syndromes; mostly BPI disorder), BP2 (BP1 plus BPII disorder), and BP3 (BP2 plus recurrent major depression). The three models include 119, 209, and 307 affected individuals, respectively. The corresponding models for psychotic BP are BP-P1, BP-P2, and BP-P3 described elsewhere. 1 They include 68, 72, and 79 affected individuals, respectively. Thus, the broadened psychotic BP sample includes an additional 228 nonpsychotic affected individuals. Our genotyping procedure is fluorescence-based, with PCR products separated and detected on ABI 377 DNA sequencers, and with allele sizes called automatically using GENOTYPER v. 2. 5 We have used 343 microsatellite markers, with average marker spacing of 10 cM and average heterozygosity and polymorphic information content of 0.75 and 0.72, respectively. The MLINK program from the FASTLINK package 6 is used for parametric linkage analysis, with the parameters described for our initial genome scan. 3 Unaffected individuals are coded as unknown, to reduce the impact of nonpenetrant disease alleles on the analysis. Table 1 shows maximum two-point lod scores for psychotic BP (taken from our previous analysis 1 ) that either meet Lander and Kruglyak's 7 criteria for genome-wide suggestive linkage (lod score X1.9) or are 'near-suggestive' ( > 1.5 but < 1.9). For the same loci, we present the maximum two-point lod scores using the 'all BP' phenotype (including nonpsychotic BP) obtained under any model configuration (current analysis; for most loci, model configurations are the same as those used originally for psychotic BP 1 ). Of the 12 regions implicated in psychotic BP, 1 eight -6q21, 8p12, 8p21, 8q24, 9q31, 10q22, 15q26, and 20q13 -show substantial reduction in lod scores ( > 1 lod unit), when the phenotype is broadened to include nonpsychotic BP. In four of these regions6q21, 8q24, 10q22, and 15q26 -support for linkage using the broad phenotype is minimal or nonexistent (lod score 50.5). Two other regions -13q32 and 17p12 -show moderate reduction in lod scores ( < 1 lod unit). On the other hand, in two regions the evidence for linkage is either unaltered -5q33 -or greatly enhanced to genome-wide significance (lod score > 3.3) 6 -18q21. Weakening of linkage signals Letters to the Editor might suggest that the original findings 1 are falsepositive. However, many of these signals are supported by previous studies of BP (though sorting out linkage to psychosis requires more study) or by studies of schizophrenia, another disorder with major psychotic features thought to have genes in common with BP. 1, [8] [9] [10] Our results suggest that for some loci psychotic and nonpsychotic variants of BP may not be part of the same genetic 'spectrum'. This supports our previous observations 1, 2 that the presence or absence of psychosis may be governed by different susceptibility loci, and that phenotypic dissection of BP may expedite the search for the underlying genes.
Further study is needed to confirm and extend these findings. Attention-deficit/hyperactivity disorder (ADHD (MIM 143465)) is a common neurobehavioral disorder characterized by childhood onset and impairment in multiple settings. ADHD affects B5% of children and adolescents and B3% of adults, with a 3-4-fold prevalence in males 1 and similar prevalence rates observed across diverse populations. Heritability estimates of 60-90% and reported sibling relative risks (l s ) of B4-8 support a strong genetic etiology. 2, 3 Currently, three genome-wide linkage studies from distinct ADHD populations have been published, one using extended kindreds from a population isolate, 4 and two others using affected sibling pair (ASP) sampling. The University of California at Los Angeles (UCLA) study 5, 6 comprises 308 ASPs and parents recruited from multiple sources in the greater Los Angeles area. 7 The Utrecht University study 8 contains 164 ASPs and parents of Dutch, Caucasian ancestry, recruited from different outpatient clinics in The Netherlands. Both studies employed the DSM-IV criteria for diagnoses of ADHD. A third genome scan in extended kindreds from a population isolate has been published, 4 and comparison to the results of the joint analysis is discussed further on.
Genome scan analyses and fine mapping investigations in the UCLA sample support significant linkage in three regions: 6q12 (MLS 3.30), 16p13 (MLS 3.73), and 17p11 (MLS 3.63), while the Utrecht two-stage genome scan supports significant linkage in two regions: 7p13 (MLS 3.04) and 15q15 (MLS 3.54). Both studies had lower linkage signals (1 < MLS < 3) at multiple locations, but only one region of overlap at 5p13 (UCLA MLS = 2.55; 6 Utrecht Broad Affection Criteria MLS = 1.43 and Narrow Criteria MLS = 0.47 8 ).
In an attempt to better interpret the lack of replication across these two data sets, we pooled genotypic data and re-analyzed the pooled sample in two ways. First, we estimate linkage evidence across the whole genome using the pooled sample and empiric P-values generated by simulations (i.e. generating empiric P-values based on 1000 replicates per chromosome using the exact marker information from the individual scans; for methods, see Ogdie et al. 4 ). For that analysis, we combined the data into a single sample and used a single linkage map constructed from the deCODE high-density map, Marshfield genetic maps, and the UCSC Genome Browser to validate the relative order of markers, and performed multipoint MLS analysis under the possible triangle (i.e. Holman's triangle; two-parameter maximization) using Genehunter v. 2.0. The Utrecht data set included 434 markers derived mostly from the Weber
